Skip to content

Short-Term Effects of Connective Tissue Massage After Hysterectomy

Short-Term Effects of Connective Tissue Massage After Hysterectomy: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05270447
Enrollment
60
Registered
2022-03-08
Start date
2020-10-12
Completion date
2021-03-01
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy, Massage, Pain

Brief summary

The aim of this study to investigate the effects of connective tissue massage (CTM) on pain, intestinal peristaltism and functionality after total laparoscopic (TLH) or abdominal hysterectomy (TAH). Patients who underwent TLH randomly group as TLH-CTM (n=15) and TLH control (n=16), and TAH randomly group as TAH-CTM (n=14) and TAH control (n=15). The postoperative daily monitoring sheet, Visual Analogue Scale (VAS), time of intestinal peristaltism employees to collect research data.

Detailed description

Interventions In the control groups (TLH control and TAH control) only in-bed activities and walking recommendations will be given, and routine care (analgesics and wound care) applies. In addition, CTM applies in the CTM groups (TLH-CTM and TAH-CTM). Connective tissue manipulation: The patients are informed about CTM and its mechanism of action before starting the CTM application. CTM is performed by a trained physiotherapist as the patient was in a sitting position. All posterior connective tissue areas (sacral, lumbar, lower thoracic, scapular, inter-scapular, and cervical) are stimulated. Both short and long strokes will use during the manipulation. Each stroke will repeate three times, first on the right and then on the left of all desired zones. All sessions will terminated with long bilateral strokes to the iliac crest and subcostal regions. During manipulation, the pad of the middle finger will be in contact with the patient's skin. Application will take approximately 30-35 minutes depending on the area treated. CTM will apply twice: at postoperative 3rd hour and after 24 hours. Routine care and advising: In-bed activities will advice to the patients in both groups. In-bed activities are; rotation, sitting on the bedside, breathing exercises, range of motion exercises for upper and lower extremities. In addition, hourly walking activities are recommended after the anesthetic effect wore off. Vital signs (pulse rate, blood pressure, and respiratory rate) and body temperatures will evaluate regularly. The investigators, will determine the severity of severe pain with the VAS scale. According to the VAS scale, if the patient reports pain intensity between 7-10 out of 10, it means that she has severe pain. Patients will encourage for early ambulation. Initially, they walked 10-15 m inside their rooms and the amount of walking increased over time.

Interventions

OTHERMassage and patient education

Connective tissue manipulation: The patients were informed about CTM and its mechanism of action before starting the CTM application. CTM was performed by a trained physiotherapist as the patient was in a sitting position. Routine care and advising: In-bed activities were taught and recommended to the patients in both groups. In-bed activities; rotation, sitting on the bedside, breathing exercises, range of motion exercises for upper and lower extremities. In addition, hourly walking activities were recommended after the anesthetic effect wore off.

BEHAVIORALRoutine care and advising

Routine care and advising: In-bed activities were taught and recommended to the patients in both groups. In-bed activities; rotation, sitting on the bedside, breathing exercises, range of motion exercises for upper and lower extremities. In addition, hourly walking activities were recommended after the anesthetic effect wore off.

Sponsors

Bozok University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

Randomized Controlled Study

Eligibility

Sex/Gender
FEMALE
Age
41 Years to 53 Years
Healthy volunteers
No

Inclusion criteria

* volunteered to participate in the study, * those who underwent benign abdominal or laparoscopic hysterectomy, * who were stable at post-operative vital signs and those with no complications in the early postoperative period

Exclusion criteria

* they had oncological diseases, * chronic pain history, prolapse, * those who had previous abdominal surgery, * those with known psychological problems. For the CTM groups, * those with local infection (abscess etc.), open lesion/wound, scar tissue, edema, and hematoma in the lumbar region.

Design outcomes

Primary

MeasureTime frameDescription
Pain scoreChange from baseline to postoperative 2 daysVisual analog scale was used to assess pain levels. The Visual analog scale, is a 10-cm horizontal line ranging from No Pain-Score 0 to Intolerable Pain-Score 10, where 0 indicates the absence of pain and 10 indicates the presence of very severe pain.Higher scores related with worse pain status.

Secondary

MeasureTime frameDescription
the time of the first defecation after the surgeryTwo daysthe time of the first defecation after the surgery
blood pressure before and after interventionsTwo daysBlood Pressure measurement before and after interventions (Systolic and Diastolic Pressure; in mmHg)
time of the first passage of flatus after the surgeryTwo daystime of the first passage of flatus after the surgery
Respiratory rates before and after interventionsTwo daysRespiratory rates measurements (Breathing rate number per minute)
The difficulty levels of the patients during functional activitiesTwo daysAssess with scoring to perceived difficulty. Patients scores difficulty in their activities of daily living 0 to 10. 0 means no difficulty, 10 means highest difficulty, very diffuculty performing activity
Heart Rate before and after interventionsTwo daysHeart Rate measurement before and after interventions (Beat per minute)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026